相关实验视频

Updated: May 27, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

探索细菌生物标志物在非胃肠道固体瘤中的预后和预测潜力

Caoimbhe Burke¹, Thomas Glynn¹, Chowdhury Jahangir¹

¹UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.

Expert review of molecular diagnostics

|February 20, 2025

概括

非胃肠道固体瘤中的瘤相关细菌正在成为关键生物标志物. 先进的技术使得它们的分析成为可能,为改善癌症预后和个性化治疗铺平了道路.

科学领域:

在瘤学瘤学.
微生物组研究微生物组研究
生物标志物发现发现

背景情况:

癌症预后的标准临床参数有限.
瘤微环境 (TME),包括细菌,显著影响癌症的进展.
研究正在扩展到超出高负载部位的非胃肠道 (GI) 固体瘤.

研究的目的:

探索细菌生物标志物在非GI固体瘤中的潜力.
审查分析瘤相关微生物的方法.
突出TME在癌症发展和存活中的作用.

主要方法:

16S rRNA 基因测序的基因测序
定量聚合酶连锁反应 (qPCR) 是一种
免疫制免疫制免疫制
在现场混合化.

主要成果:

这些技术允许对实体瘤中的微生物进行详细分析.
已确立的微生物生物标志物存在于GI和其他癌症 (例如,H. 皮洛里病毒,HPV).
对乳腺,肺和胰腺等非胃肠道固体瘤的兴趣越来越大.

结论:

协议的标准化对于可靠的细菌标记物开发至关重要.
适当的样本处理和数据分析是必不可少的.
细菌生物标志物可以提高癌症预后,预测和个性化治疗计划.

关键词:

癌症癌症癌症癌症细菌细菌细菌是一种细菌.生物标志物生物标志物预测预测预测预测预后预后预后

更多相关视频

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

相关概念视频

Serum Laboratory Studies, Stool Test, Breath Test

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...